Qualitis SA, is a Full-Service Clinical Research and Medical Consulting CRO Company, which is recently acquired by Optimapharm Group, Qualitis is offering a comprehensive portfolio of clinical development and medical consulting services to the Pharmaceutical, Biotechnology and Medical Device industries. Through a commitment to a Company culture of superior quality service, integrity and innovation, Qualitis focuses on exceeding its customers particular needs and expectations. Qualitis Team possesses an in-depth and long-term experience and expertise in both clinical research and medical-marketing environment and is strongly dedicated in constant learning and continuous improvement driven to create added value for our customers and become an integral part of their business success. With a strong focus on people and standards, Qualitis has built upon the 3 milestones of business success: Quality, Commitment and Customer Trust. Our specialty areas include but are not limited to the following: -Cardiovascular diseases -Neurology & Psychiatry -Pulmonary/Respiratory -Genitourinary -Gastroenterology -Oncology -Orthopedics -Pediatrics -Biotechnology -Allergy/Immunology -Dermatology -Virology -Endocrinology -Hematology -Ophthalmology Areas of Operation-Projects Portfolio: -Phase II-IV Clinical Trials -Medical Device Studies -Non-Interventional Studies -Pharmacovigilance Studies -IIS (Investigator Initiated Studies) -Epidemiological Studies -Market Surveys Customers Profile: -Pharmaceutical Companies -Biotechnology Companies -Medical Devices Companies -Academic Research Institutes & Hospitals -International CROs Contact Details: E-mail: info@qualitis.gr Telephone: +30 210-7797750 Fax: +30 210-7470441